One form of chromosome instability (CIN), the recurrent missegregation of whole chromosomes during cell division (W-CIN), leads to aneuploidy. Although W-CIN is a hallmark of most cancers, mutations in genes involved in chromosome segregation are exceedingly rare. We discuss an oncogene-induced mitotic stress model that provides a mechanistic framework to explain this paradox. We also review the tumor-promoting and tumor-suppressing consequences of W-CIN. Importantly, we do this in the context of cancer as a complex systemic disease, rather than as a simple linearly progressing disorder that arises from a single abnormal cell population. Accordingly, we highlight the often neglected effects of W-CIN on key non-cell-autonomous entities, such as the immune system and the tumor microenvironment. Distinct tissue-specific susceptibilities to W-CIN-induced tumorigenesis and the clinical implications of W-CIN are also discussed.
Cancer cells frequently missegregate their chromosomes during mitosis. This phenomenon, known as whole-chromosome instability (W-CIN) leads to aneuploidy, a hallmark of most solid tumors. As extensively discussed elsewhere, tumor cells acquire W-CIN through three major mechanisms: mitotic checkpoint defects, centrosome overduplication or faulty sister chromatid cohesion (Figure 1, bottom) . [1] [2] [3] [4] [5] Briefly, the mitotic checkpoint ensures faithful chromosome segregation during mitosis by delaying anaphase onset until all chromosomes have aligned on the metaphase plate. A weakened mitotic checkpoint results in premature chromosome segregation. More commonly, the overexpression of checkpoint components leads to a prolonged mitosis, which also leads to chromosome missegregation. 2 As a result of centrosome overduplication, tumor cells often acquire three or more centrosomes per cell. Even though centrosome clustering typically results in a normal-appearing bipolar mitosis, the formation of improper microtubule-kinetochore attachments leads to frequent chromosome missegregation events. 6 Finally, cohesion defects cause premature separation of the sister chromatids. 7, 8 Here, we discuss the recently proposed oncogene-induced mitotic stress model that provides a mechanistic framework for the long-standing paradox that the majority of cancers are aneuploid, whereas mutations in genes involved in chromosome segregation are extremely rare in tumors. We will also assess pertinent immediate effects of W-CIN on the tumor cell. Importantly, however, we call special attention to the consequences of W-CIN in the context of cancer as a complex systemic disease, rather than as one in which W-CIN merely contributes to tumor progression in a simple linear, cell-autonomous fashion. Does the cell type in which W-CIN arises influence its tumorigenic effects? What are the consequences of W-CIN for interactions with the tumor microenvironment? How does the immune system cope with W-CIN tumor cells? How does W-CIN affect metastasis? Do the respective outcomes promote or suppress tumorigenesis? In this review, we will discuss these questions with an emphasis on the often overlooked non-cell-autonomous consequences of W-CIN in cancer.
ONCOGENE-INDUCED MITOTIC STRESS
To explain why most human tumors are aneuploid in the absence of mutations in W-CIN genes, the term 'oncogene-induced mitotic stress' was recently introduced. 9 The basic idea is that commonly activated oncogenes or inactivated tumor-suppressor genes directly or indirectly affect mitotic processes that control chromosome segregation ( Figure 1 ). For example, overexpression of the Ras oncogene, which mimics the mutational overactivation of Ras that is frequently observed in human tumors, 10 induces centrosome overduplication, anaphase bridges and the formation of multipolar mitotic spindles. The consequent chromosome missegregation leads to aneuploidy and the formation of micronuclei and binucleate cells. 11 Similar mitotic defects are observed upon amplification of CDK4, which encodes cell cycledependent kinase 4, and oncogenic mutations in a downstream activator of the Ras pathway, B-Raf, both of which are also common in human cancers.
leads to improper attachments and lagging chromosomes. 22 In one study, the function of p53 to maintain genomic stability was elegantly dissociated from its apoptosis-inducing properties. Homozygous p53 R172P knock-in mice carry alleles that encode a mutant form of p53 that maintains the ability to induce p21 expression, yet is unable to trigger apoptosis. 23 These animals develop tumors with stable, diploid genomes. However, in this context, p21 loss, which results in the activation of E2F and Mad2 overexpression, leads to the formation of highly aneuploid tumors with shorter latencies, indicating that p21 induction is a critical means by which p53 prevents genomic instability. 24 Remarkably, by reducing the protein levels of Mad2, alleviation of at least part of the stress on the mitotic checkpoint in this setting, as well as in a Rb-defective mammary tumor model, is sufficient to rescue W-CIN. 21 
SUSCEPTIBILITY TO W-CIN-INDUCED TUMORIGENESIS IS TISSUE-SPECIFIC
Factors that might determine to what extent W-CIN causes cellular transformation include its origin, or cell type, and the stromal environment or tissue that surrounds it. A number of studies using mouse models have shown that W-CIN may cause or accelerate tumorigenesis more readily in some organs than in others. To assess which tumor sites are most commonly affected by W-CIN, we compiled data from 14 separate mouse models that have previously been published. We limited our analysis to single-gene models that spontaneously develop solid aneuploid tumors and, for each tumor site, only included data when a minimum of 2 studies with a total of at least 30 animals were available. The overall increases in tumor incidence in W-CIN mouse models compared with non-W-CIN control animals were calculated per tumor site and tumor type (Figure 2a ). This analysis indicates that W-CIN increases tumor development at all organ sites and in all cell types studied (Figures 2b and c) . W-CIN induces the most significant absolute increase in tumorigenesis in lung, liver and lymphoid organs. However, the percentage (or fold) increase in W-CIN-induced tumor formation is higher in blood vessels and skin (Figure 2b) . Similarly, although the absolute increase in W-CIN-induced tumorigenesis is highest for carcinomas, followed by lymphomas and sarcomas, respectively, in terms of fold increase, this order is reversed (Figure 2c ). Thus, W-CIN is a potent driver of tumorigenesis as it not only exacerbates tumor incidence in inherently more susceptible tissues but also augments tumorigenesis in tissues that normally have a very low propensity to form tumors.
W-CIN has also been shown to cause a switch in the observed tumor spectrum in mouse tumor models. For instance, p53 À / À mice primarily develop thymic lymphomas. However, concomitant reduction of the protein level of the mitotic checkpoint enzyme Separase, which on its own does not cause tumorigenesis, leads to increased W-CIN and the development of a wider variety of aneuploid malignancies, including ones that originate from the spleen and bone marrow. 25 Interestingly, in the p53
mutant knock-in mouse model that develops euploid tumors, mainly sarcomas, 23 p21 loss predominantly leads to the formation of aneuploid lymphomas 24 and rescue of the aneuploidy by Mad2 normalization in the latter model also reverses the tumor spectrum to that observed in p53 R172P/R172P animals. 21 Strikingly, these examples are consistent with W-CIN inducing a greater increase in lymphomagenesis than in sarcomagenesis in W-CIN mouse models involving a single genetic defect (Figure 2c ). Together, these observations provide strong evidence for the existence of tissue-specific differences in the susceptibility to W-CIN-induced tumorigenesis.
Finally, some organs may have an increased propensity to become aneuploid because of certain inherent properties of their cells. The liver is a particularly notorious example in this regard. A tendency to become polyploid has been observed in hepatocytes of a wide variety of mammalian species. 26 In fact, these cells frequently increase and reduce their ploidy status through failed cytokinesis and multipolar mitosis, respectively. The dynamic nature of these processes has been shown to inevitably lead to the acquisition of numerical chromosome abnormalities. 27, 28 This Figure 1 . Oncogene-induced mitotic stress. Most human tumors are aneuploid, but mutations in genes involved in chromosome segregation are rare. Key oncogenic and tumor suppressor pathways (top) control the gene expression and/or activity of an array of proteins involved in faithful chromosome segregation during mitosis (bottom). Aberrations in these pathways impose a mitotic stress that leads to W-CIN, thus explaining why most tumors are aneuploid. Superscript-and þ indicate common inactivating and activating aberrations in human tumors, respectively. Proteins in red font are direct E2F transcriptional targets; [134] [135] [136] those in blue font are p53 transcriptional targets. 137, 138 Targets of both are shown in green.
may explain why the liver is particularly amenable to W-CINinduced tumorigenesis in mice ( Figure 2b ) and why liver tumors are among the ones with the highest aneuploidy rates in humans. 29 
TUMOR-PROMOTING EFFECTS OF W-CIN
Cell-autonomous tumor-promoting effects The genesis of tumors is a process that involves a stepwise acquisition of multiple malignant features. Hanahan and Weinberg 30 described eight hallmarks of cancer to better understand the course of tumor development conceptually (Figure 3, bottom) . In addition, two characteristics have been proposed to facilitate the acquisition of these features: genomic instability and inflammation by innate immune cells. 30 Indeed, genomic instability, which comprises both chromosome instability (CIN) and microsatellite instability (MIN), 31 is the only cell-autonomous feature that provides the evolving tumor cell with a mechanism that fosters unremitted genomic and mutational plasticity leading to survival, proliferation and dissemination ( Figure 3 and Table 1) . 32 In essence, therefore, W-CIN drives tumor progression by accelerating the gain of oncogenic and the loss of tumorsuppressor loci, thus facilitating the acquisition of each of the eight hallmarks of cancer. Consistently, W-CIN accelerates tumor formation and increases tumor burden and malignancy in a wide range of in vivo settings. 2, 4, 21 In addition to this direct tumor-promoting effect, wholechromosome missegregation has been demonstrated in a variety of contexts to trigger other forms of genomic instability-as well as epigenetic changes and oxidative stress [33] [34] [35] [36] -that further facilitate tumor progression ( Figure 3) . In mouse models of W-CIN, loss of Pttg, which encodes securin, a target of the mitotic checkpoint, leads to increased levels of DNA damage. 37 Moreover, W-CIN is accompanied by structural chromosomal aberrations in Figure 3 . Cell-intrinsic and -extrinsic factors affect the acquisitionor loss-of cancer-promoting properties. Genomic instability, comprising CIN and MIN, is the primary cell-autonomous driver of tumor progression as it instigates genetic and genomic abnormalities (gains, losses, duplications, deletions, rearrangements, DNA damage, mutations) that contribute to the acquisition of the eight hallmarks of cancer (bottom). 30 Non-cell-autonomous factors from the tumor micro-environment and the immune system can similarly support or restrain tumor development. Tumor-suppressive effects include the loss or reversion of the acquisition of malignant features, as well as the induction of cell cycle arrest, apoptosis, necroptosis, senescence or autophagy. See also main text for details. 88 (n). These studies were selected because: (1) the experimental animals had but a single genetic defect that leads to W-CIN (i.e., they had no additional commonly used driver mutations in other oncogenes or tumor suppressor genes), (2) the genetic defect affected the animals globally (i.e., all organs and tissues) and (3) tumors arose spontaneously (i.e., were not induced by carcinogens). (a) Using the respective reports, numbers of animals in each category were added and the indicated percentages were calculated. (b, c) W-CIN-induced tumorigenesis affects different organs (b) and cell types (c) disproportionately. As compared with non-W-CIN animals, W-CIN increases the tumor incidence in all of the indicated organs and cell types. However, some of these differences are not statistically significant (*Po0.05; **Po0.01; ***Po0.0001; ns, not significant; one-sided Fisher's exact test). In terms of absolute increases, liver, lung and lymphoid organs are significantly more susceptible to W-CIN-induced tumor formation than blood vessel endothelium or skin. Similarly, the absolute increase in W-CIN-induced development of carcinomas is larger than those of lymphomas and sarcomas (two-sided Fisher's exact tests).
tumors that develop in animals overexpressing the mitotic checkpoint protein Mad2, as well as in primary cells heterozygous for Cdh1 or overexpressing aurora B. 20, 38, 39 Thus, W-CIN induces an avalanche of further genomic damage, instability and mutations, a trait that has been referred to as the mutator phenotype ( Figure 3 ). 40 Several recent studies provide additional evidence to support the idea that W-CIN and aneuploidy provoke a mutator phenotype. In both fission and baker's yeast, the presence of an extra chromosome causes various forms of genomic instability, including increased rates of DNA damage, mutations, wholechromosome loss and mitotic recombination. 41 Interestingly, the authors find that the genomic instability in these aneuploid yeast cells is due to excess protein and not to excess DNA. In yeast and primary mouse cells, this phenomenon had previously already been shown to result in proteotoxic stress and changes in cellular metabolism. 42, 43 This can lead to oxidative stress, 36, 44 which could explain the observed DNA damage. In mammalian cells, W-CINrather than aneuploidy per se-also causes other types of genomic instability. W-CIN cells often have a prolonged metaphase. This culminates in telomere dysfunction and DNA damage at chromosome ends. 45 In addition, lagging chromosomes, which are usually caused by improper microtubule-kinetochore attachments in W-CIN cells, often become trapped in the cleavage furrow during cytokinesis, the final stage of cell division. This results in DNA double-strand breaks that are incorrectly repaired by non-homologous end joining, thus producing daughter cells that suffer structural chromosome aberrations, including unbalanced translocations. 46 Inaccurate (merotelic) microtubulekinetochore attachments have also been reported to result in pericentromeric DNA breaks in mutant mouse cells with mitotic spindle defects. 47 However, in human tumor cells, such aberrant attachments often cause hyperstabilization of microtubulekinetochore interactions, resulting in elevated chromosome missegregation rates. 22 Finally, lagging chromosomes can be encapsulated in micronuclei that form independently of the primary nucleus in tissue culture models. Following extensive DNA damage, DNA breaks and chromosomal rearrangements inside the micronucleus, the structurally altered chromosome can segregate into the primary nucleus of daughter cells. 48 In this manner, W-CIN could directly cause chromothripsis, the shredding and structural rearrangement of genomic fragments within chromosomes. 49, 50 Whether this phenomenon will be observed in mouse models of chromosome missegregation is an important unanswered question. Nonetheless, recent cancer genome sequencing efforts suggest that it is characteristic for all forms of advanced human cancer. [51] [52] [53] [54] [55] It remains unclear how some of the above in vivo and in vitro studies relate to several previous observations in other mouse models of mitotic checkpoint regulators. Mice hypomorphic for Bub1 or haploinsufficient for Bub3/Rae1 exhibit W-CIN and develop aneuploid tumors but do not show any signs of DNA damage or structural chromosomal abnormalities. 56, 57 Also, if aneuploidy, or the presence of an extra chromosome, by itself facilitates genomic instability, including continued chromosome missegregation, 41 Down syndrome would be expected to be accompanied by increased aneuploidy and elevated solid cancer susceptibility, but the opposite is true. [58] [59] [60] Conversely, Klinefelter patients, who carry one or more additional X chromosomes per cell, are at an increased risk of developing cancer-although that may be because of the inherent hormonal deregulation. 61, 62 Perhaps the degree of other genomic damage-or protection from it-that is triggered by aneuploidy is dependent on which specific chromosome(s) or loci are gained or lost. Another, not necessarily mutually exclusive, possibility is that the gain of smaller chromosomes, such as chromosome 21, has less detrimental effects because smaller chromosomes encode fewer proteins, thus causing less stress because of increased protein production. 41, 42, 63 Consistent with this, in both mice and humans, trisomies for larger autosomes cause either embryonic or perinatal lethality, such as in Patau syndrome (trisomy 13) and Edwards syndrome (trisomy 18). 43, 64 Future studies might shed more light on the above paradox.
Non-cell-autonomous tumor-promoting effects W-CIN can also, directly and indirectly, accelerate tumor progression by affecting non-cell-autonomous mechanisms: evasion of anti-tumor immunity, triggering inflammation and remodeling of the tumor microenvironment ( Figure 3 and Table 1) . 65 Elevated chromosome missegregation rates, as well as the consequences of the ensuing mutator phenotype, increase the likelihood that tumor cells will be able to evade eradication by the immune system. 31, 66 This may occur in a variety of ways. First, the adaptive immune system may no longer recognize the W-CIN cancer cell. This can be due either to the loss or mutation of tumor-specific antigens or to the acquisition of defects in antigen processing or presentation. 67, 68 Second, the genomically unstable tumor cells may become insensitive to destruction by cytotoxic cells of the 65 The complex tumorsuppressive (see also below) and tumor-promoting interactions between W-CIN tumors and the cells of the immune system can lead to the in vivo selection and survival of specific cancer cells that can permanently evade destruction by the immune system. This phenomenon is known as cancer immunoediting. 70, 71 Thus, W-CIN might facilitate cancer immunoediting in tumor cells. 69 Additionally, W-CIN may inadvertently lead to the tumor cell's secreting one or more of the many factors that recruit inflammatory immune cells or promote tissue remodeling, including tumor angiogenesis. For instance, elevated expression of the proinflammatory factors cyclooxygenase 2 (Cox-2) and interleukin-6 (IL-6) has been observed in the colon mucosa of a heterozygous-null mouse model for Sgo1, which encodes the chromosome cohesion factor Shugoshin-1 72 ( Figure 1 ). Cox-2 deficiency protects against mutant adenomatous polyposis coli-induced colon carcinogenesis, 73, 74 and IL-6 is essential for colitis-associated colon cancer development in the mouse. 65 This suggests that these factors could play an important role in the Sgo1 þ / À phenotype. It is not clear yet whether elevated expression of Cox-2 and IL-6 is a direct result of the W-CIN and whether it is confined to this particular W-CIN tumor model. We note, however, that prolonged DNA damage signaling, a consequence of W-CIN, leads to the secretion of inflammatory cytokines, 75 and in one mouse model, W-CIN has been associated with cancer progression through predisposition to chronic inflammation. 76 Finally, W-CIN can induce necrosis or apoptosis, either by virtue of random genetic changes or as a result of excessive W-CIN or genomic instability (see below), and while these forms of cell death may protect against tumor progression, they also trigger an inflammatory response that promotes tumorigenesis. 65 Collectively then, these observations suggest that W-CIN may accelerate tumor progression in vivo by creating an inflammatory environment.
Inflammation and tissue changes in the tumor milieu, including the recruitment of tumor-associated macrophages and neutrophils, facilitate tumor progression in a multitude of ways. They include the immune cells' production of growth factors, cytokines, chemokines, matrix metalloproteinases, prostaglandins and angiogenic factors, which stimulate survival, proliferation, invasion, angiogenesis, migration, extravasation and metastasis of malignant cells and weaken the anti-tumor adaptive immune response. 65, 77 Moreover, inflammation is associated with cytokine release and has been shown to induce tumor-promoting epigenetic changes, structural chromosomal abnormalities and, through the generation of reactive oxygen and nitrogen species, DNA damage, all of which in turn promote further genomic aberrations (Figure 3) . [78] [79] [80] Specific dampening of these inflammatory responses by genetic or drug intervention will be required to determine the contribution to W-CIN-induced disease.
It is important to note that W-CIN models created by global lossor gain-of-function also likely change the chromosome stability in cells of the tumor microenvironment. These changes could affect the ability of these cells to support tumor growth in a positive or negative way. Here then, conditional inactivation of the genes controlling W-CIN in specific cell types will be required. Lung tumor cell-specific overexpression of Mad2 does have a significant impact on oncogenic Kras-induced tumorigenesis 81 independent of any W-CIN effects on the microenvironment, but this does not rule out compounding effects if Mad2 overexpression in the tumor cell is combined with that in the tumor microenvironment.
TUMOR-SUPPRESSIVE EFFECTS OF W-CIN
Cell-autonomous tumor-suppressive effects The random nature of chromosome missegregation and its consequences inherently implies that as much as W-CIN can facilitate the acquisition of tumor-promoting features, it is equally likely to facilitate the loss of such characteristics and the gain of tumor-suppressive properties ( Figure 3 and Table 1 ). 32 Outcomes of the latter may include apoptosis, necroptosis (that is, programmed necrosis 82 ), senescence and autophagy (that is, the controlled lysosomal degradation of damaged or non-functional molecules or organelles within the cell 83, 84 ). Consistently, as compared with control cells, a modestly increased fraction of primary cells that exhibit W-CIN undergo cell death and/or enter senescence (see also below). 20, 37, 56, 57, 85 W-CIN and aneuploidy have also been shown to slow the proliferation rate of cells. This has been observed in aneuploid mouse embryonic fibroblasts that are trisomic and harbor Robertsonian fusion chromosomes. 43 Additionally, with very few exceptions, 28, 86 primary mouse embryonic fibroblasts derived from genetic W-CIN models grow more slowly than wild-type control fibroblasts 20, 38, [85] [86] [87] [88] and form colonies less efficiently. 20, 28 One explanation for this may lie in the fact that cells with extra copies of chromosomes suffer substantial proteotoxic stress because of increased protein production. 42, 43, 63 Another may be that, in an attempt to accurately segregate sister chromatids during mitosis, W-CIN cells prolong their metaphase. In addition to slowing the cell cycle and the production of aneuploid progeny, such extended mitotic arrest may result in the formation of binucleate cells, which proliferate more slowly or not at all. 20, [89] [90] [91] Alternatively, DNA damage, another consequence of W-CIN, may be responsible. W-CIN can cause DNA damage in vitro and in vivo 20, [46] [47] [48] and excessive amounts of DNA damage have been shown to induce apoptosis. 92 Moreover, DNA damage triggers a response that, in early stages of tumorigenesis, delays tumor progression or prevents tumorigenesis altogether. 93 The rate at which cells missegregate their chromosomes also affects whether W-CIN is beneficial or detrimental for tumor initiation and progression. Low rates of W-CIN are advantageous as they enable the steady acquisition of malignant features. Excessive W-CIN, however, results in a form of cell death during or immediately after mitosis that has been termed mitotic catastrophe. 94, 95 This phenomenon may explain why cells and animals that are completely deficient in key regulators of chromosome segregation are not viable, whereas heterozygous knockout cells and mice often are, but exhibit W-CIN, resulting in aneuploid tumor formation. 2, 4 As mentioned above, W-CIN cells attempt to faithfully segregate chromosomes during mitosis by prolonging metaphase. Increasing evidence indicates that when this arrest lasts too long, as is imperative in the case of excessive W-CIN, cells die in mitosis. 96, 97 Alternatively, mitotic slippage leads to the cell's entering the next G 1 stage of the cell cycle, after which it may permanently arrest or undergo apoptosis. 89, [95] [96] [97] [98] Several lines of evidence suggest that the p53 pathway is critically important for sensing excessive amounts of W-CIN, and the resulting genomic damage, and inducing cell cycle arrest, senescence or cell death. A p53-dependent checkpoint that arrests cells in G 1 following mitotic slippage limits the proliferation of aneuploid cells. 45, [89] [90] [91] [98] [99] [100] [101] An effective tumor-suppressive response to DNA damage and telomere dysfunction critically relies on p53 function. 102, 103 P53 prevents aneuploidy-induced transformation in vivo by inducing cell death, 36 and in C57BL/6 mice, p21 loss only leads to the development of aneuploid tumors when p53 cannot induce apoptosis. 24 Finally, only one study has thus far reported the recovery of viable cells with extreme levels of W-CIN and this required p53 loss. 104 Non-cell-autonomous tumor-suppressive effects How W-CIN may be tumor suppressive-or, as outlined above, tumor promoting-as a result of inducing non-cell-autonomous effects has thus far been poorly acknowledged. The mechanisms and consequences of genomic instability are often studied on the The cancer biology of W-CIN PHG Duijf and R Benezra molecular and cell biological levels. However, it is important to realize that tumors, particularly larger ones, are not merely a homogeneous mass of malignant cells. Not only do they often consist of different clones of cancer cells that have acquired shared as well as distinct genetic changes that allow them to proliferate, 105 they also contain a variety of normal cell types, including fibroblasts, endothelial cells and pericytes of the tumor vasculature, as well as various types of immune cells. 30, 106 CD4 þ T cells, CD8 þ T cells, natural killer T cells, natural killer cells, tumorassociated macrophages, dendritic cells and neutrophils can act to promote tumor progression under certain conditions, but all these cell types, as well as mast cells, Tie-2-expressing monocytes, mesenchymal stem cells, fibroblasts and pericytes, have also been found to possess anti-tumor activity.
65,107-109 W-CIN, and the consequent other forms of genomic damage, can lead to the tumor cell's producing signals that stimulate their own eradication by cytotoxic leukocytes or inhibit their growth facilitation by other cell types. One such signal could be the production of novel immunogenic proteins due to, for instance, mutations or translocations. Such proteins are also known as tumor-specific antigens and are actively sought after in order to develop cancer immunotherapies. 110 It is conceivable (but not yet shown) that W-CIN can also trigger non-cell-autonomous antimetastatic effects. For example, during tumorigenesis, cancer cells acquire the ability to entrain neutrophils to actively kill tumor cells at the premetastatic site and thereby inhibit seeding and colonization by these cells. 111 In principle, this type of change could be enhanced by W-CIN in the tumor cell. In addition, in the tumor cell, W-CIN may result in changes in the expression levels of certain factors that are critical for metastasis-such as the microRNA miR-126-that would then in turn protect the metastatic site from the recruitment of endothelial cells, angiogenesis and colonization. 112 Ultimately, however, as the tumor continues to evolve, such tumorsuppressive barriers may be overcome, after which metastasis does occur.
Finally, in one mouse model, W-CIN induced by the loss of one copy of Cenpe, which encodes a kinetochore motor protein involved in chromosome segregation, has been shown to reduce the incidence of tumorigenesis in some settings. 28 However, in this study, as well as in all other single-gene W-CIN models that have thus far been created, the induction of aneuploidy is global, that is, in all cells and tissues of the animal, thereby affecting the tumor microenvironment and possibly inhibiting tumor growth. In future studies, it will be important to examine the consequences of genetically induced W-CIN in a specific cell type or organ in the context of a wild-type tumor microenvironment and immune system.
CLINICAL IMPLICATIONS OF W-CIN
The ability to missegregate chromosomes equips cancer cells with a mechanism that fuels tumor progression. Consistently, aneuploidy, the immediate consequence of W-CIN, has been associated with poor prognostic factors for a variety of cancers (Table 2) . 29, 113 These include correlations with higher tumor grade, increases in tumor recurrence and decreases in metastasis-free and overall patient survival. In line with this, primary tumors that are aneuploid have an increased likelihood to metastasize and metastatic tumors often exhibit more chromosomal aberrations than the primary tumors. For example, the brain metastases of colorectal carcinomas have more structural and numerical chromosomal abnormalities than the matched primary tumors. 114 W-CIN increases the risk for lymph node metastasis of squamous cell carcinomas 115 and aneuploidy is associated with poorer overall survival in breast, ovarian, lung and brain cancers (Table 2) . 29, 113, [116] [117] [118] Importantly, one study has shown that even though W-CIN is more frequent in metastasized pulmonary tumors, its presence in the primary tumor is not necessarily a reliable prognostic marker for metastatic potential. 119 Additionally, other studies have demonstrated that, before a clinically manifest metastasis, early disseminated breast, esophageal and prostate carcinoma cells in the lymph nodes or bone marrow exhibit significantly fewer whole-chromosome and segmental chromosomal aberrations than the matched primary tumors. [120] [121] [122] [123] Together, these results suggest that at a time when primary tumors have adapted to use aneuploidy to fuel tumor growth, there may be selective pressure against the most aneuploid cells in the population in early metastatic events. Once the metastatic niche is established, then rapid tumor evolution may once again allow the expansion of the more aneuploid and aggressive cell populations.
Regardless of the order of genetic and genomic events, another malignant clinical consequence of W-CIN is enhanced resistance to cancer treatment. 124 W-CIN has been associated with multidrug resistance 125 and, in the context of breast and ovarian cancer, it Breast cancer A W-CIN signature/score correlates with higher tumor grade, poorer survival and shorter times to recurrence and metastasis in patients with most breast cancer subtypes. 113, 116, 117 Cervical carcinoma Aneuploidy status is a better prognostic predictor than lymph node metastasis status. 149 Colorectal carcinoma Brain metastases have more chromosomal aberrations and whole-chromosome gains and losses than the primary tumors. 114, 150 Gastrointestinal stromal tumors (GIST)
Increased AURKA expression and aneuploidy rates are associated with an elevated metastasis rate. 151 Glioma A W-CIN signature correlates with poorer patient survival. 113 Lung adenocarcinoma Aneuploidy and a W-CIN signature correlate with poorer patient prognosis. 113, 152 Lymphoma A W-CIN signature correlates with poorer patient survival. 113 Medulloblastoma A W-CIN signature correlates with poorer patient survival. 113 Melanoma Aneuploidy correlates with poorer patient survival. 153 Ovarian carcinoma Aneuploidy correlates with higher tumor grade and increased risk of recurrence. Whole-chromosome aneuploidy correlates with poorer patient survival. 29, 118 Squamous cell carcinoma Increased aneuploidy rates reduce disease-free and overall survival and increase the risk of lymph node metastasis. 115, 154 Thyroid carcinoma Metastases are more often aneuploid than primary tumors. 155 The cancer biology of W-CIN PHG Duijf and R Benezra has been shown to confer resistance to taxanes. 126 Taxanes are microtubule-stabilizing drugs that are commonly used in chemotherapy and are thought to induce cell death by causing a prolonged mitotic arrest. 96, 97, 127 Finally, W-CIN is responsible for tumor recurrence after oncogene withdrawal, which may reflect resistance to targeted anticancer therapies. 81 In this regard, the ongoing chromosomal changes may lead to the tumor cells' becoming insensitive to therapy, for example, due to loss of the target or the acquisition of other pro-proliferative signals that permit the re-growth of the tumor even when target pathway inhibition is effective.
THERAPEUTIC TARGETING OF W-CIN TUMOR CELLS
Because W-CIN is an important driver of tumor progression, an approach that specifically targets W-CIN tumor cells is likely to be effective against most forms of cancer. Several such strategies have been proposed. As mentioned above, an excessively high level of W-CIN results in cell death. The possibility of increasing the levels of W-CIN in tumor cells in order to eradicate them has therefore been explored in vitro. Indeed, a combination of reducing the expression level of the mitotic kinases Mps1 or BubR1 and treatment with the taxane paclitaxel induces cell death. 128 However, at present, the development of a therapeutic strategy based on this principle remains both challenging and precarious.
Another strategy involves the specific inhibition of centrosome clustering. Tumor cells have often overduplicated their centrosomes such that they possess more than the normal number of two centrosomes per cell (Figure 1 ). Centrosome clustering allows cells to undergo a bipolar division, but this frequently leads to aneuploid daughter cells secondary to merotelic chromosome attachments and lagging chromosomes. 6 The use of various drugs, such as griseofulvin and EM011, and small-molecule inhibitors or small interfering RNAs against various mitotic proteins, including HSET and HEC1, have shown various degrees of specificity in inhibiting the proliferation of cancer cells with overduplicated centrosomes. [129] [130] [131] [132] The latter study has in fact demonstrated some in vivo efficacy. 132 In addition to these approaches that aim to target W-CIN cells per se, other strategies have focused on targeting the resulting aneuploid cells. The presence of an additional chromosome in disomic yeast or in trisomic mouse embryonic fibroblasts, generated by Robertsonian fusion chromosomes, has been shown to cause aberrations in cellular metabolism and protein folding and turnover. 42, 43 Importantly, three drugs that induce energy stress or inhibit autophagy or protein folding have been shown to specifically inhibit proliferation of the aforementioned trisomic mouse embryonic fibroblasts and aneuploid human cells. 133 It remains unclear, however, whether these agents will be effective in specifically killing aneuploid cells that have lost chromosomes, a phenomenon that is in fact more common in human tumors. 29 Finally, aneuploid cells may be targeted specifically by virtue of a common gain or loss of a whole chromosome, a chromosome arm or a combination thereof. Chromosome 7 is frequently gained in solid tumors, particularly in carcinomas, and chromosome 22 is often lost, for example, in nearly half of ovarian adenocarcinomas. 29 Similarly, an approach that combines targeting the gain of chromosome 7 and the loss of chromosome 10 is anticipated to be effective for up to 75% of glioblastomas and astrocytomas. 29, 53 The small arms of chromosomes 3 and 8 are frequently lost and gained in tumors, respectively. 52, 53 The gains and/or losses of these whole chromosomes or chromosome arms, or deletions or amplification of smaller chromosome segments, may be targeted using the respective increased or decreased expression of one or multiple genes on the involved chromosomes. Genes encoding cell membrane proteins would represent the most promising candidates. The observation that the copy number of genes in aneuploid cells is proportional to the transcript and protein levels of the gene 32 predicts that this may become a feasible option.
CONCLUSIONS AND PERSPECTIVES
As discussed above, W-CIN has tumor-promoting and tumorsuppressive effects (Table 1 ). The question of what determines the fate of a cell that missegregates its chromosomes may be embedded in the temporal order of events. Oncogene (or tumor-suppressor loss)-induced mitotic stress is likely an early event that exacts a temporary fitness cost before the expansion of more aneuploid and more aggressive stress-resistant progeny. Enough missegregation and mutator events likely need to occur to efficiently drive tumor progression. Early dissemination events and the population of the early metastatic niche may counterselect initially for the cells in the population with fewer chromosomal imbalances until these cells can once again tolerate the stress of growing in a hostile tumor microenvironment. Thus, the evolutionary process of tumorigenesis involves overcoming multiple critical tumor-suppressive barriers that are put in place in a normal cell and W-CIN is one mechanism that facilitates the breaking of these barriers. Importantly, in this review, we underscored that non-cell-autonomous factors also have a critical influence on this W-CIN-driven selection process. Similar to the macroevolution of species in which key genetic changes that drive adaptation occur over thousands or millions of years, this microevolutionary process may be very slow, as evidenced by the fact that it may take decades until an incipient tumor cell has developed into full-blown metastatic disease. The dynamic nature of W-CIN has several undesirable clinical consequences, such as the increased likelihood of tumor recurrence and the acquisition of resistance to cancer therapies. It has also significantly hampered the development of aneuploidyspecific regimens. However, over the past decades, a number of promising strategies have emerged. The further improvement of these strategies and the design of novel ones may in the not too distant future lead to the development of more effective cancer treatment options.
